Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1. Validation and Calibration Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye

NCT01348633 is registered in ClinicalTrials.gov with University of Toronto as lead sponsor.

NCT NCT01348633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01348633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1. Validation and Calibration Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye
Lead sponsor
University of Toronto
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2012
Completion date
August 31, 2015
Enrollment
275 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

branch retinal artery occlusion, branch retinal vein occlusion, central retinal artery occlusion, central retinal vein occlusion